Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Brain Neoplasms 6Neoplasm Metastasis 2Hematologic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Multiple Myeloma 1Meningioma 1Lymphoma 1Lung Neoplasms 1Leukemia 1Cognitive/Functional Effects 1Cognitive Dysfunction 1Breast Neoplasms, Male 1Breast Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Dexamethasone 124Lenalidomide 72daratumumab 71Bortezomib 58pomalidomide 47carfilzomib 42Cyclophosphamide 39Calcium Dobesilate 36Specimen Handling 31Biopsy 29Magnetic Resonance Spectroscopy 26belantamab mafodotin 22isatuximab 21fludarabine 20iberdomide 18talquetamab 17Melphalan 15dexamethasone acetate 14dexamethasone 21-phosphate 14auricularum 14fludarabine phosphate 13elotuzumab 12selinexor 10tocilizumab 9X-Rays 8Nivolumab 8trametinib 7Whole-Body Irradiation 7Sirolimus 7Mycophenolic Acid 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Myeloma × Mental Status and Dementia Tests × 90 days × Clear all
NCT05011045 2026-05-20

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

M.D. Anderson Cancer Center

Recruiting
100 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡